1. Home
  2. CYTH vs NSYS Comparison

CYTH vs NSYS Comparison

Compare CYTH & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • NSYS
  • Stock Information
  • Founded
  • CYTH 1990
  • NSYS 1981
  • Country
  • CYTH United States
  • NSYS United States
  • Employees
  • CYTH N/A
  • NSYS N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • NSYS Industrial Machinery/Components
  • Sector
  • CYTH Health Care
  • NSYS Technology
  • Exchange
  • CYTH Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • CYTH 26.2M
  • NSYS 29.0M
  • IPO Year
  • CYTH N/A
  • NSYS N/A
  • Fundamental
  • Price
  • CYTH $0.76
  • NSYS $9.84
  • Analyst Decision
  • CYTH Buy
  • NSYS
  • Analyst Count
  • CYTH 3
  • NSYS 0
  • Target Price
  • CYTH $0.95
  • NSYS N/A
  • AVG Volume (30 Days)
  • CYTH 44.3K
  • NSYS 6.6K
  • Earning Date
  • CYTH 03-17-2025
  • NSYS 03-19-2025
  • Dividend Yield
  • CYTH N/A
  • NSYS N/A
  • EPS Growth
  • CYTH N/A
  • NSYS 109.80
  • EPS
  • CYTH N/A
  • NSYS 1.55
  • Revenue
  • CYTH $870,725.00
  • NSYS $135,567,000.00
  • Revenue This Year
  • CYTH N/A
  • NSYS N/A
  • Revenue Next Year
  • CYTH $24.49
  • NSYS N/A
  • P/E Ratio
  • CYTH N/A
  • NSYS $6.44
  • Revenue Growth
  • CYTH N/A
  • NSYS N/A
  • 52 Week Low
  • CYTH $0.55
  • NSYS $9.53
  • 52 Week High
  • CYTH $1.92
  • NSYS $19.15
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 54.14
  • NSYS 42.79
  • Support Level
  • CYTH $0.70
  • NSYS $9.77
  • Resistance Level
  • CYTH $0.87
  • NSYS $10.38
  • Average True Range (ATR)
  • CYTH 0.07
  • NSYS 0.32
  • MACD
  • CYTH -0.00
  • NSYS 0.02
  • Stochastic Oscillator
  • CYTH 49.91
  • NSYS 35.94

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

Share on Social Networks: